World Medicine Ranks Third Among Türkiye’s R&D Champions
World Medicine, one of the prominent representatives of Türkiye’s pharmaceutical industry, is drawing attention with its achievements in research and development (R&D). The company has once again proven its strong position in the sector with the results it achieved in the Turkey R&D 500 Research.
According to the research, World Medicine managed to secure third place on the list with a total of 125 brands. The company states that it supports this success with its strong production infrastructure and high export capacity. Focusing on innovative work in the pharmaceutical sector, the firm continues to contribute to the Turkish economy.
World Medicine officials state that R&D and innovation are at the center of the company's strategies. Projects developed at its production facilities in Türkiye increase the company's competitive power in both the local market and the international arena. These efforts also highlight the importance of domestic production in the pharmaceutical sector.
Such research, which measures Türkiye’s technology and innovation capacity, is of great importance in terms of tracking the development of companies. The level reached by World Medicine shows how valuable R&D investments are in the pharmaceutical sector. The company has announced that it aims to continue growing with new projects in the coming period.